PrecorDx

A new dimension in cardiac sensing

Heart Failure

Heart failure affects the lives of million of people worldwide. Clinicians treating these patients strive to slow disease progression, reduce symptom burden and improve quality of life. However, patients are faced with thousands of emergency hospital admissions due to heart failure decompensation each year. These relapses are one of the main drivers of healthcare expenditure, reduce the prognosis and require hospital admissions typically stretching multiple days.

Current diagnostic and monitoring tools struggle with diagnostic ambiguity. Alterations in cardiac haemodynamics often precede over clinical signs of heart failure decompensation by days or weeks. This leaves heart failure monitoring through weight measurements or symptom reporting reactive rather than preventive. Implantable hemodynamic heart failure sensors are invasive, expensive and available for a very limited number of patients. In patients with heart failure where systolic cardiac function is preserved, abnormalities in cardiac function only become apparent during exercise.

Technology

We build a new dimension in cardio-pulmonary diagnostics. Applying deep insights in physics, mathematics, and clinical physiology, we are developing radiofrequency sensing (RFS), a novel class of sensor technology that enables precise, non-invasive measurement of cardiac deformation.